Free Trial
LON:AREC

Arecor Therapeutics (AREC) Share Price, News & Analysis

Arecor Therapeutics logo
GBX 42.33 -5.67 (-11.81%)
As of 03/28/2025 12:16 PM Eastern

About Arecor Therapeutics Stock (LON:AREC)

Key Stats

Today's Range
42.33
48
50-Day Range
42.33
58.98
52-Week Range
42.33
170
Volume
29,002 shs
Average Volume
14,676 shs
Market Capitalization
£15.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com

Remove Ads
Receive AREC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AREC Stock News Headlines

Trump… a socialist?
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Arecor Full Year 2024 Trading Update
Arecor inks licensing deal for AT351
See More Headlines

AREC Stock Analysis - Frequently Asked Questions

Arecor Therapeutics' stock was trading at GBX 73.75 at the beginning of the year. Since then, AREC shares have decreased by 42.6% and is now trading at GBX 42.33.
View the best growth stocks for 2025 here
.

Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arecor Therapeutics investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Lowe's Companies (LOW) and SNDL (SNDL).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Coal
Current Symbol
LON:AREC
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-10,683,346.07
Net Margins
-176.89%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£6.04 million
Cash Flow
GBX 8.35 per share
Price / Cash Flow
5.07
Book Value
GBX 16.58 per share
Price / Book
2.55

Miscellaneous

Free Float
N/A
Market Cap
£15.98 million
Optionable
Not Optionable
Beta
-0.18
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (LON:AREC) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners